Phosphonate compounds
US-9206208-B2 · Dec 8, 2015 · US
US8946243B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8946243-B2 |
| Application number | US-93476909-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2009 |
| Priority date | Mar 28, 2008 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to compounds and methods for treating or preventing a viral infection, by administering a monophosphorylated prodrug of acyclovir or monophosphorylated derivative of an acyclovir prodrug to a subject suffering from or susceptible (to a viral infection, such as HIV infection.
Opening claim text (preview).
We claim: 1. A compound represented by the formula (Formula I): wherein: Ar is an aryl group having 6 to 30 carbon atoms or a heteroaryl group having 6 to 30 atoms, wherein the aryl or heteroaryl group may be substituted with 1-3 substituents; Q is O, S, or CR 4 R 5 , wherein R 4 and R 5 are independently selected from H and C 1 -C 6 alkyl; X is H, or CH 2 OH; R…
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.